Privat: News - emergers.se

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

2022-08-30• Analys

Besides completing a capital raise in these challenging market conditions, KebNi enjoys strong business momentum with new antenna orders...

Read More →

CAPSEK: Stark underliggande tillväxt i CapSeks portföljbolag trots negativt resultat

2022-08-28• Interview, Okategoriserade

Trots ett negativt nettoresultat på 5 MSEK för det andra kvartalet 2023, fortsätter Northern CapSek Ventures ABs portfölj att uppvisa...

Read More →

DLABORATORY: Welcome boost from booming attention on power grid stability

2022-08-26• Analys

The rise of network stability and electricity security on the public agenda has finally started to translate into a material rise in...

Read More →

HILBERT GROUP: Light at the end of the tunnel | Read our interview with Niclas Sandström, CEO Hilbert Group

2022-08-25• Analys, Research

In the first half of 2022 we have seen the collapse of Luna, several big crypto companies struggle and both Bitcoin and Ether price tumble...

Read More →

MEDS: Strong momentum in pharmacy market’s transition to online

2022-08-23• Analys

With a proprietary tech platform, 80-130% retention rates and a Net Promotor Score (NPS) of 72/100, MEDS is on track to capture the SEK...

Read More →

SWEDISH STIRLING: Protracted negotiations shades short term outlook – while long term case remains strong

2022-08-23• Analys, Research

Strengthened by the support of renowned names in the upcoming green preference share issue Swedish Stirling now stands ready to deliver to...

Read More →

TALLINK: Kalibrerar affärsmodellen

2022-08-18• Okategoriserade

ANALYSSAMARBETE MED ENLIGHT RESEARCH Rapporten för det andra kvartalet var bättre än vi räknat med, framförallt efter justeringar...

Read More →

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

2022-08-18• Analys

In line with their strategic plan to move into the highest margin application areas, Simris Alg announced an LOI to acquire Cyano Biotech...

Read More →

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

2022-08-10• Analys, Research

As a result of the ongoing preparations of the DFS for Dannemora, GRANGEX now reports an upwards revision of the known and indicated...

Read More →

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

2022-08-05• Analys

With the new CEO in place, Simris has now set course to pursue the most high value application area for microalgae, the biopharma sector in...

Read More →

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

CAPSEK: Stark underliggande tillväxt i CapSeks portföljbolag trots negativt resultat

DLABORATORY: Welcome boost from booming attention on power grid stability

HILBERT GROUP: Light at the end of the tunnel | Read our interview with Niclas Sandström, CEO Hilbert Group

MEDS: Strong momentum in pharmacy market’s transition to online

SWEDISH STIRLING: Protracted negotiations shades short term outlook – while long term case remains strong

TALLINK: Kalibrerar affärsmodellen

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

GRANGEX: Progress and project improvement against prolonged favorable macro backdrop

SIMRIS ALG: Targeting biopharma to exploit highest value verticals in the microalgae and cyanobacteria space

Widmark Research

CONTACT